13D/13G Filings - Altitude Life Science Ventures Fund II L.P.

Real time Form 13D and 13G transaction reports:

  • Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
  • Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
  • Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
Time period
Reported
DateTime
Transaction
Date
TypeCompany
Symbol
Filed By
Symbol
Shares Owned
% Owned
Shares Vs. Prev ReportView
2024-02-05
4:15 pm
Purchase
2023-12-3113GeFFECTOR Therapeutics, Inc.
EFTR
Altitude Life Science Ventures Fund II L.P.2,826,350
4.400%
2,713,296increase
(+2400.00%)
Filing
History
2023-03-07
5:25 pm
Purchase
2021-08-2513GeFFECTOR Therapeutics, Inc.
EFTR
Altitude Life Science Ventures Fund II L.P.113,054
6.700%
113,054increase
(New Position)
Filing
History